US7629384B2
(en)
*
|
1997-09-17 |
2009-12-08 |
Strategic Science & Technologies, Llc |
Topical delivery of L-arginine to cause beneficial effects
|
US7914814B2
(en)
*
|
1997-09-17 |
2011-03-29 |
Strategic Science & Technologies, Llc |
Topical delivery of arginine of cause beneficial effects
|
US6576660B1
(en)
*
|
1997-10-31 |
2003-06-10 |
Arch Development Corporation |
Methods and compositions for regulation of 5-α-reductase activity
|
US6946144B1
(en)
*
|
1998-07-08 |
2005-09-20 |
Oryxe |
Transdermal delivery system
|
US7220427B2
(en)
*
|
1998-07-08 |
2007-05-22 |
Oryxe |
Mixture for transdermal delivery of low and high molecular weight compounds
|
US9006175B2
(en)
|
1999-06-29 |
2015-04-14 |
Mannkind Corporation |
Potentiation of glucose elimination
|
ITMI991894A1
(it)
*
|
1999-09-09 |
2001-03-09 |
Carlo Ghisalberti |
Acido linoleico coniugato e trigliceride nuovi metodi di sintesi e d'uso
|
DE10009424A1
(de)
*
|
2000-02-28 |
2001-09-06 |
Henkel Kgaa |
Verwendung von Flavonen oder Isoflavonen zur Cellulite-Behandlung
|
US20060121103A1
(en)
*
|
2000-05-11 |
2006-06-08 |
Kenneth Kirby |
Transdermal delivery system
|
FR2811562B1
(fr)
*
|
2000-07-13 |
2003-03-07 |
Oreal |
Composition, notamment cosmetique, renfermant la dhea et un isoflavonoide
|
FR2811566B1
(fr)
*
|
2000-07-13 |
2003-01-17 |
Oreal |
Composition, notamment cosmetique, renfermant la dhea et/ou ses precurseurs ou derives, et une vitamine
|
US20040198706A1
(en)
*
|
2003-03-11 |
2004-10-07 |
Carrara Dario Norberto R. |
Methods and formulations for transdermal or transmucosal application of active agents
|
US7214381B2
(en)
|
2000-08-03 |
2007-05-08 |
Antares Pharma Ipl Ag |
Composition for transdermal and/or transmucosal administration of active compounds that ensures adequate therapeutic levels
|
US7198801B2
(en)
*
|
2000-08-03 |
2007-04-03 |
Antares Pharma Ipl Ag |
Formulations for transdermal or transmucosal application
|
US8980290B2
(en)
|
2000-08-03 |
2015-03-17 |
Antares Pharma Ipl Ag |
Transdermal compositions for anticholinergic agents
|
FR2812873B1
(fr)
|
2000-08-11 |
2003-08-01 |
Barry Callebaut France |
Procede de production de polyphenols a partir de feves de cacao
|
EP1180331B1
(de)
*
|
2000-08-16 |
2008-07-09 |
Unilever N.V. |
Mischungen von Isoflavonen und Flavonen
|
ES2309030T3
(es)
|
2000-08-16 |
2008-12-16 |
Unilever N.V. |
Mezclas de isoflanonas y flavonas.
|
US6503894B1
(en)
|
2000-08-30 |
2003-01-07 |
Unimed Pharmaceuticals, Inc. |
Pharmaceutical composition and method for treating hypogonadism
|
FR2815858B1
(fr)
*
|
2000-10-26 |
2003-12-12 |
Oreal |
Composition, notamment cosmetique, renfermant la dhea et/ou ses precurseurs ou derives, et un agent susceptible d'inhiber l'irritation d'origine neurogene
|
AU1482102A
(en)
*
|
2000-11-14 |
2002-05-27 |
Tocovite Pty Ltd |
Complexes of phosphate derivatives
|
AUPR549901A0
(en)
|
2001-06-06 |
2001-07-12 |
Vital Health Sciences Pty Ltd |
Topical formulation containing tocopheryl phosphates
|
FR2818135B1
(fr)
|
2000-12-15 |
2003-02-14 |
Oreal |
Composition, notamment cosmetique, renfermant la 7-hydroxy dhea et/ou la 7-ceto dhea et au moins un carotenoide
|
FR2818148B1
(fr)
|
2000-12-15 |
2005-06-24 |
Oreal |
Composition,notamment cosmetique, renfermant, la 7-hydroxy dhea et/ou la 7-ceto dhea et au moins un isoflavonoide
|
US6607735B2
(en)
|
2000-12-21 |
2003-08-19 |
Johnson & Johnson Consumer Companies, Inc. |
Method for reducing the appearance of dark circles under the eyes
|
NL1017333C2
(nl)
*
|
2001-02-12 |
2002-08-13 |
Gent Natural Products Van |
Cosmetisch resp. farmaceutisch preparaat.
|
US6589591B1
(en)
*
|
2001-07-10 |
2003-07-08 |
Baylor College Of Medicine |
Method for treating medical devices using glycerol and an antimicrobial agent
|
AU2002317053B2
(en)
*
|
2001-07-27 |
2004-08-05 |
Vital Health Sciences Pty Ltd |
Dermal therapy using phosphate derivatives of electron transfer agents
|
CA2459647A1
(en)
*
|
2001-08-20 |
2003-02-27 |
University Of Virginia Patent Foundation |
Use of s-nitrosothiol signaling to treat disordered control of breathing
|
US8795716B2
(en)
|
2001-10-01 |
2014-08-05 |
The Procter & Gamble Company |
Skin care compositions on a thin sanitary napkin
|
US20050089495A1
(en)
*
|
2001-12-13 |
2005-04-28 |
West Simon M. |
Transdermal transport of compounds
|
US20030199581A1
(en)
*
|
2002-03-13 |
2003-10-23 |
Seligson Allen L. |
Boswellin compositions enhanced with 3-beta-acetyl-11-keto-beta-boswellic acid ("AKBA") industrial manufacture and uses
|
CA2479751C
(en)
|
2002-03-20 |
2008-06-03 |
Trent Poole |
Inhalation apparatus
|
US7235249B2
(en)
|
2002-03-28 |
2007-06-26 |
The Procter & Gamble Company |
Methods for regulating the condition of mammalian keratinous tissue via topical application of vitamin B6 compositions
|
DE10228680A1
(de)
*
|
2002-06-27 |
2004-01-22 |
Holden Development Limited, Tortola |
Grundlage für transdermale Formulierungen (PTF)
|
US7099713B2
(en)
|
2002-06-28 |
2006-08-29 |
Battelle Memorial Institute |
Skin conduction and transport systems
|
AU2002950713A0
(en)
*
|
2002-08-09 |
2002-09-12 |
Vital Health Sciences Pty Ltd |
Carrier
|
US20040062794A1
(en)
*
|
2002-09-30 |
2004-04-01 |
Lee Shulman |
17Beta- estradiol/levonorgestrel transdermal patch for hormone replacement therapy
|
US9035123B2
(en)
|
2002-10-01 |
2015-05-19 |
The Procter & Gamble Company |
Absorbent article having a lotioned topsheet
|
JP2006510674A
(ja)
*
|
2002-12-06 |
2006-03-30 |
ボード オブ リージェンツ ザ ユニバーシティー オブ テキサス システム |
脂質:エモジン製剤に関する組成物および方法
|
WO2004064831A1
(en)
*
|
2003-01-17 |
2004-08-05 |
Vital Health Sciences Pty Ltd |
Compounds having anti-proliferative properties
|
US20060141443A1
(en)
*
|
2003-01-21 |
2006-06-29 |
Gyory J R |
Apparatus and method for transcellular testing
|
WO2004091521A2
(en)
*
|
2003-04-10 |
2004-10-28 |
Neurogesx, Inc. |
Methods and compositions for administration of trpv1 agonists
|
US7033998B2
(en)
*
|
2003-04-11 |
2006-04-25 |
All Natural Fmg, Inc. |
Alcohol-free transdermal insulin composition and processes for manufacture and use thereof
|
US7052715B2
(en)
*
|
2003-04-11 |
2006-05-30 |
All Natural Fmg, Inc. |
Alcohol-free transdermal analgesic composition and processes for manufacture and use thereof
|
AU2003901815A0
(en)
*
|
2003-04-15 |
2003-05-01 |
Vital Health Sciences Pty Ltd |
Phosphate derivatives
|
FR2855753B1
(fr)
*
|
2003-06-03 |
2007-09-14 |
Dermo Cosmologie Lab De |
Composition a base de diosgenine applicable par voie topique
|
US20050058673A1
(en)
|
2003-09-09 |
2005-03-17 |
3M Innovative Properties Company |
Antimicrobial compositions and methods
|
ATE534373T1
(de)
|
2003-10-10 |
2011-12-15 |
Antares Pharma Ipl Ag |
Transdermale pharmazeutische formulierung zur minimierung von rückständen auf der haut
|
US6998109B1
(en)
|
2004-01-07 |
2006-02-14 |
Pearson Research & Development Limited |
Emu-based formulations with lidocaine for wound treatment by inhibiting microbial activity
|
US7585850B2
(en)
*
|
2004-02-10 |
2009-09-08 |
Adenobio N.V. |
Stable and active complexes of adenosine and adenosine phosphates with aminoalcohols for the treatment of pulmonary artery hypertension, cardiac failure and other diseases
|
US20050271597A1
(en)
*
|
2004-02-13 |
2005-12-08 |
Keith Alec D |
Prostate hypertrophy treatment composition and method
|
JP5376761B2
(ja)
*
|
2004-02-23 |
2013-12-25 |
ストラテジック サイエンス アンド テクノロジーズ, エルエルシー |
身体の外観および皮膚の外観を改善するための、一酸化窒素の局所送達
|
ATE495730T1
(de)
*
|
2004-03-03 |
2011-02-15 |
Vital Health Sciences Pty Ltd |
Alkaloid-formulierungen
|
CA2561496A1
(en)
*
|
2004-04-02 |
2005-10-20 |
Baylor College Of Medicine |
Novel modification of medical prostheses
|
US20050226827A1
(en)
*
|
2004-04-09 |
2005-10-13 |
Thienna Ho |
Skin lightening composition
|
US9226909B2
(en)
|
2004-04-19 |
2016-01-05 |
Strategic Science & Technologies, Llc |
Beneficial effects of increasing local blood flow
|
US20110028548A1
(en)
*
|
2004-04-19 |
2011-02-03 |
Strategic Science & Technologies, Llc |
Beneficial effects of increasing local blood flow
|
WO2005102282A1
(en)
*
|
2004-04-19 |
2005-11-03 |
Strategic Science & Technologies, Llc |
Transdermal delivery of beneficial substances effected by a hostile biophysical environment
|
US7425340B2
(en)
*
|
2004-05-07 |
2008-09-16 |
Antares Pharma Ipl Ag |
Permeation enhancing compositions for anticholinergic agents
|
US20050272700A1
(en)
*
|
2004-05-10 |
2005-12-08 |
Servet Buyuktimkin |
Topical treatment and prevention of human papilloma virus (HPV) infection
|
ES2385934T3
(es)
|
2004-08-20 |
2012-08-03 |
Mannkind Corporation |
Catálisis de la síntesis de dicetopiperazina.
|
KR101644250B1
(ko)
|
2004-08-23 |
2016-07-29 |
맨카인드 코포레이션 |
약물 전달용 디케토피페라진염, 디케토모르포린염 또는 디케토디옥산염
|
AU2005291862B2
(en)
*
|
2004-10-08 |
2010-07-08 |
Clinuvel Pharmaceuticals Limited |
Compositions and methods for inducing melanogenesis in a subject
|
US9415034B2
(en)
*
|
2005-01-05 |
2016-08-16 |
National Defense Medical Center |
Inhibitors and enhancers of uridine diphosphate-glucuronosyltransferase 2B (UGT2B)
|
BRPI0607461A2
(pt)
*
|
2005-02-14 |
2009-09-08 |
Neurogesx Inc |
dispositivo para liberação de agonistas de trpv1
|
US20090233881A1
(en)
*
|
2005-03-03 |
2009-09-17 |
Vital Health Sciences Pty. Ltd |
Compounds having anti-cancer properties
|
BRPI0608690B8
(pt)
|
2005-03-10 |
2021-05-25 |
3M Innovative Properties Co |
uso de uma composição antimicrobiana
|
BRPI0608691A2
(pt)
|
2005-03-10 |
2010-12-07 |
3M Innovative Properties Co |
composição antimicrobiana, e, métodos para matar ou inativar microorganismos em tecido da mucosa de um mamìfero, para tratar uma lesão ou ferimento infectado, para descolonização de microorganismos, para proporcionar eficácia antimicrobiana residual sobre uma superfìcie e para tratar uma condição
|
EP1865933B1
(de)
*
|
2005-03-30 |
2015-11-04 |
Vanderbilt Royalty Sub L.P. |
Capsaicin-pflaster mit geringer konzentration und verfahren zur behandlung von neuropathischem schmerz
|
WO2007124250A2
(en)
|
2006-04-21 |
2007-11-01 |
Antares Pharma Ipl Ag |
Methods of treating hot flashes with formulations for transdermal or transmucosal application
|
US7563464B1
(en)
|
2005-04-22 |
2009-07-21 |
Bruce Eric Hudkins |
Treatment of mucosal membranes utilizing phytoestrogen
|
US7252834B2
(en)
*
|
2005-04-25 |
2007-08-07 |
Clemson University Research Foundation (Curf) |
Elastin stabilization of connective tissue
|
WO2006125642A1
(en)
|
2005-05-27 |
2006-11-30 |
Antares Pharma Ipl Ag |
Methods and apparatus for transdermal or transmucosal application of testosterone
|
NZ565049A
(en)
*
|
2005-06-17 |
2012-02-24 |
Vital Health Sciences Pty Ltd |
A carrier comprising one or more DI and/or mono-(electron transfer agent) phosphate derivatives or complexes thereof
|
DK1928423T3
(en)
|
2005-09-14 |
2016-02-29 |
Mannkind Corp |
A method for drug formulation based on increasing the affinity of the active substances to the crystalline microparticle surfaces
|
EP1940346A2
(de)
*
|
2005-09-30 |
2008-07-09 |
The Procter and Gamble Company |
Zusammensetzung zur regulierung des keratingewebes von säugetieren
|
US8911751B2
(en)
|
2005-10-11 |
2014-12-16 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Compositions for nasal delivery
|
US7920926B2
(en)
*
|
2005-12-09 |
2011-04-05 |
Apsara Medical Corporation |
Method and apparatus for carrying out the controlled heating of tissue in the region of dermis
|
FR2894811B1
(fr)
†
|
2005-12-21 |
2008-02-22 |
Oreal |
Composition cosmetique a effet volumateur
|
TW200800223A
(en)
*
|
2005-12-21 |
2008-01-01 |
Shire Pharmaceuticals Inc |
Transdermal delivery of meptazinol
|
US20070196301A1
(en)
|
2005-12-21 |
2007-08-23 |
L'oreal |
Cosmetic composition with a volumizing effect
|
JP2009520697A
(ja)
*
|
2005-12-23 |
2009-05-28 |
バイタル ヘルス サイエンシズ プロプライアタリー リミティド |
サイトカイン調節性を有する化合物
|
WO2007086931A1
(en)
*
|
2006-01-24 |
2007-08-02 |
Majid Fotuhi |
Dosage regimen and medicament for preventing of reducing risk of onset or progression of dementia by administration of specific vitamins and nsaid
|
US8039431B2
(en)
|
2006-02-22 |
2011-10-18 |
Mannkind Corporation |
Method for improving the pharmaceutic properties of microparticles comprising diketopiperazine and an active agent
|
US20090221703A1
(en)
|
2006-07-09 |
2009-09-03 |
Chongxi Yu |
High penetration composition and uses thereof
|
US20090238763A1
(en)
|
2006-07-09 |
2009-09-24 |
Chongxi Yu |
High penetration compositions and uses thereof
|
WO2008007684A1
(fr)
*
|
2006-07-14 |
2008-01-17 |
National University Corporation Hokkaido University |
Agent promoteur de surrefroidissement
|
EP3210964A1
(de)
|
2006-07-18 |
2017-08-30 |
Techfields Biochem Co. Ltd |
Positivgeladene, wasserlösliche prodrugs von ibuprofen mit einer sehr schnellen hautpenetrationsrate
|
EP2756843A3
(de)
|
2006-07-25 |
2014-08-20 |
Techfields Biochem Co. Ltd |
Positiv geladene, wasserlösliche Prodrugs von Diclofenac mit sehr schneller Hautpenetrationsrate
|
CN101506160A
(zh)
|
2006-08-08 |
2009-08-12 |
于崇曦 |
具有快速皮肤穿透速度的带正电荷的芳基和杂芳基乙酸类前药
|
EP2084132B1
(de)
|
2006-09-03 |
2018-08-08 |
Techfields Biochem Co. Ltd |
Positiv geladene wasserlösliche prodrugs von n-arylanthranilsäuren mit sehr schneller hautpenetrationsgeschwindigkeit
|
ES2670407T3
(es)
|
2006-09-03 |
2018-05-30 |
Techfields Biochem Co. Ltd |
Profármacos de acetaminofén solubles en agua cargados positivamente y compuestos relacionados con una tasa de penetración de la piel muy rápida
|
US20080075793A1
(en)
*
|
2006-09-21 |
2008-03-27 |
Dunshee Wayne K |
Antiviral compositions and methods of use
|
CN101535240B
(zh)
*
|
2006-10-02 |
2015-07-22 |
于崇曦 |
具有快速皮肤穿透速度的带正电荷的水溶性的前列腺素及相关化合物的前药
|
CN101522692A
(zh)
|
2006-10-11 |
2009-09-02 |
于崇曦 |
具有快速皮肤穿透速度的带正电荷的水溶性的昔康及其相关化合物的前药
|
US20080097557A1
(en)
*
|
2006-10-19 |
2008-04-24 |
Apsara Medical Corporation |
Method and apparatus for carrying out the controlled heating of tissue in the region of dermis
|
WO2008049454A1
(en)
*
|
2006-10-23 |
2008-05-02 |
Ecolab Inc. |
Virucidal composition
|
US20100086495A1
(en)
*
|
2007-02-15 |
2010-04-08 |
Derma-Young Ltd. |
Compositions and methods for enhancing transmucosal delivery
|
JP2010529101A
(ja)
*
|
2007-06-04 |
2010-08-26 |
テックフィールズ インコーポレイテッド |
非常に速い皮膚及び膜浸透速度を有するnsaiaプロドラッグ及びその新規医薬使用
|
JP2010539245A
(ja)
|
2007-09-14 |
2010-12-16 |
日東電工株式会社 |
薬物担体
|
WO2009064806A1
(en)
*
|
2007-11-12 |
2009-05-22 |
Endologix, Inc. |
Method and agent for in-situ stabilization of vascular tissue
|
GB0801119D0
(en)
|
2008-01-22 |
2008-02-27 |
Barry Callebaut Ag |
Composition
|
US20090214654A1
(en)
*
|
2008-02-21 |
2009-08-27 |
Isenburg Jason C |
Treatment of aneurysm with application of connective tissue stabilization agent in combination with a delivery vehicle
|
CN107088227A
(zh)
|
2008-03-28 |
2017-08-25 |
粒子科学有限公司 |
用于使治疗剂增溶的药物溶液和方法
|
AU2009257311B2
(en)
|
2008-06-13 |
2014-12-04 |
Mannkind Corporation |
A dry powder inhaler and system for drug delivery
|
US8485180B2
(en)
|
2008-06-13 |
2013-07-16 |
Mannkind Corporation |
Dry powder drug delivery system
|
US9364619B2
(en)
|
2008-06-20 |
2016-06-14 |
Mannkind Corporation |
Interactive apparatus and method for real-time profiling of inhalation efforts
|
KR20130115392A
(ko)
*
|
2008-06-25 |
2013-10-21 |
이엘씨 매니지먼트 엘엘씨 |
피부 및 신체 외관 개선 방법 및 조성물
|
US20100016833A1
(en)
*
|
2008-07-15 |
2010-01-21 |
Ogle Matthew F |
Devices for the Treatment of Vascular Aneurysm
|
TWI532497B
(zh)
|
2008-08-11 |
2016-05-11 |
曼凱公司 |
超快起作用胰島素之用途
|
US9101599B2
(en)
|
2008-09-15 |
2015-08-11 |
Laila Nutraceuticals |
Synergistic anti-inflammatory compositions comprising Boswellia serrata extracts
|
US20100119605A1
(en)
*
|
2008-11-12 |
2010-05-13 |
Isenburg Jason C |
Compositions for tissue stabilization
|
WO2010065936A1
(en)
|
2008-12-04 |
2010-06-10 |
Chongxi Yu |
High penetration compositions and their applications
|
US8314106B2
(en)
|
2008-12-29 |
2012-11-20 |
Mannkind Corporation |
Substituted diketopiperazine analogs for use as drug delivery agents
|
JP5667095B2
(ja)
|
2009-03-11 |
2015-02-12 |
マンカインド コーポレイション |
吸入器の抵抗を測定するための装置、システムおよび方法
|
CA2764505C
(en)
|
2009-06-12 |
2018-09-25 |
Mannkind Corporation |
Diketopiperazine microparticles with defined specific surface areas
|
US11684624B2
(en)
|
2009-06-24 |
2023-06-27 |
Strategic Science & Technologies, Llc |
Treatment of erectile dysfunction and other indications
|
EP2445493A1
(de)
|
2009-06-24 |
2012-05-02 |
Strategic Science & Technologies, LLC |
Topische zusammensetzung mit naproxen
|
RU2505291C2
(ru)
|
2009-06-24 |
2014-01-27 |
СТРАТЕДЖИК САЙЕНС ЭНД ТЕКНОЛОДЖИЗ, ЭлЭлСи |
Топическая композиция, содержащая ибупрофен
|
WO2011044455A1
(en)
*
|
2009-10-09 |
2011-04-14 |
Vatrix Medical, Inc. |
In vivo chemical stabilization of vulnerable plaque
|
US8444624B2
(en)
*
|
2009-10-19 |
2013-05-21 |
Vatrix Medical, Inc. |
Vascular medical devices with sealing elements and procedures for the treatment of isolated vessel sections
|
WO2011056889A1
(en)
|
2009-11-03 |
2011-05-12 |
Mannkind Corporation |
An apparatus and method for simulating inhalation efforts
|
US9554994B2
(en)
|
2009-12-16 |
2017-01-31 |
Ecolab Usa Inc. |
Composition in form of a gel for the virucidal disinfection of mammalian skin
|
US10071030B2
(en)
|
2010-02-05 |
2018-09-11 |
Phosphagenics Limited |
Carrier comprising non-neutralised tocopheryl phosphate
|
AU2010345338B2
(en)
*
|
2010-02-15 |
2014-03-13 |
Laila Nutraceuticals |
A novel Boswellia low polar gum resin extract and its synergistic compositions
|
US8828377B2
(en)
|
2010-03-15 |
2014-09-09 |
Laila Nutraceuticals |
Boswellia oil, its fractions and compositions for enhancing brain function
|
ES2829386T3
(es)
|
2010-03-30 |
2021-05-31 |
Phosphagenics Ltd |
Parche de administración transdérmica
|
RU2571331C1
(ru)
|
2010-06-21 |
2015-12-20 |
Маннкайнд Корпорейшн |
Системы и способы доставки сухих порошковых лекарств
|
ES2811515T3
(es)
|
2010-12-29 |
2021-03-12 |
Strategic Science & Tech Llc |
Tratamiento de disfunción eréctil y otras indicaciones
|
JP2014501283A
(ja)
|
2010-12-29 |
2014-01-20 |
ストラテジック サイエンス アンド テクノロジーズ, エルエルシー |
アレルギーおよび他の適応症の処置のためのシステムおよび方法
|
US8911468B2
(en)
|
2011-01-31 |
2014-12-16 |
Vatrix Medical, Inc. |
Devices, therapeutic compositions and corresponding percutaneous treatment methods for aortic dissection
|
TR201101374A1
(tr)
|
2011-02-14 |
2012-09-21 |
Sanovel İlaç Sanayi̇ Ve Ti̇caret Anoni̇m Şi̇rketi̇ |
Flurbiprofen ve metilsülfonilmetanın topikal farmasötik bileşimleri.
|
WO2012122586A1
(en)
|
2011-03-15 |
2012-09-20 |
Phosphagenics Limited |
New composition
|
CN105667994B
(zh)
|
2011-04-01 |
2018-04-06 |
曼金德公司 |
用于药物药盒的泡罩包装
|
TR201103183A1
(tr)
*
|
2011-04-01 |
2012-10-22 |
Sanovel İlaç Sanayi̇ Ve Ti̇caret Anoni̇m Şi̇rketi̇ |
Ketoprofen ve metilsülfonilmetanın topikal farmasötik bileşimleri.
|
TR201103770A1
(tr)
|
2011-04-19 |
2012-11-21 |
Sanovel İlaç Sanayi̇ Ve Ti̇caret Anoni̇m Şi̇rketi̇ |
Nimesulid ve metilsülfonilmetanin topikalfarmasötik bileşimleri.
|
JP2014516695A
(ja)
|
2011-05-18 |
2014-07-17 |
バトリックス・メディカル・インコーポレイテッド |
血管安定化用被覆バルーン
|
WO2012174472A1
(en)
|
2011-06-17 |
2012-12-20 |
Mannkind Corporation |
High capacity diketopiperazine microparticles
|
CA2852536A1
(en)
|
2011-10-24 |
2013-05-02 |
Mannkind Corporation |
Methods and compositions for treating pain
|
US9301920B2
(en)
|
2012-06-18 |
2016-04-05 |
Therapeuticsmd, Inc. |
Natural combination hormone replacement formulations and therapies
|
PT2782584T
(pt)
|
2011-11-23 |
2021-09-02 |
Therapeuticsmd Inc |
Preparações e terapias de substituição para hormonoterapias naturais combinadas
|
WO2013089656A1
(en)
|
2011-12-16 |
2013-06-20 |
Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi |
Topical pharmaceutical compositions of thiocolchicoside and methylsulfonylmethane
|
RU2683934C2
(ru)
|
2012-05-16 |
2019-04-03 |
Текфилдз Фарма Ко., Лтд. |
Композиции, содержащие пролекарства с высокой проницаемостью, и фармацевтическая композиция для лечения состояний легких
|
US20130338122A1
(en)
|
2012-06-18 |
2013-12-19 |
Therapeuticsmd, Inc. |
Transdermal hormone replacement therapies
|
US20150196640A1
(en)
|
2012-06-18 |
2015-07-16 |
Therapeuticsmd, Inc. |
Progesterone formulations having a desirable pk profile
|
US10806740B2
(en)
|
2012-06-18 |
2020-10-20 |
Therapeuticsmd, Inc. |
Natural combination hormone replacement formulations and therapies
|
US10806697B2
(en)
|
2012-12-21 |
2020-10-20 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
US9283241B2
(en)
|
2012-07-10 |
2016-03-15 |
Clemson University |
Treatment to render implants resistant to diabetes
|
US9802012B2
(en)
|
2012-07-12 |
2017-10-31 |
Mannkind Corporation |
Dry powder drug delivery system and methods
|
WO2014024193A1
(en)
*
|
2012-08-07 |
2014-02-13 |
Prodel Pharma Ltd. |
Compositions and methods for rapid transmucosal delivery of pharmaceutical ingredients
|
US10159644B2
(en)
|
2012-10-26 |
2018-12-25 |
Mannkind Corporation |
Inhalable vaccine compositions and methods
|
US10471072B2
(en)
|
2012-12-21 |
2019-11-12 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
US11266661B2
(en)
|
2012-12-21 |
2022-03-08 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
US10537581B2
(en)
|
2012-12-21 |
2020-01-21 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
US9180091B2
(en)
|
2012-12-21 |
2015-11-10 |
Therapeuticsmd, Inc. |
Soluble estradiol capsule for vaginal insertion
|
US11246875B2
(en)
|
2012-12-21 |
2022-02-15 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
US10568891B2
(en)
|
2012-12-21 |
2020-02-25 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
ES2754388T3
(es)
|
2013-03-15 |
2020-04-17 |
Mannkind Corp |
Composiciones y métodos de dicetopiperazina microcristalina
|
US9925144B2
(en)
|
2013-07-18 |
2018-03-27 |
Mannkind Corporation |
Heat-stable dry powder pharmaceutical compositions and methods
|
EP3030294B1
(de)
|
2013-08-05 |
2020-10-07 |
MannKind Corporation |
Insufflationsvorrichtung
|
CN105813690A
(zh)
|
2013-08-21 |
2016-07-27 |
协和大学 |
树状聚合物-白藜芦醇复合物
|
US10307464B2
(en)
|
2014-03-28 |
2019-06-04 |
Mannkind Corporation |
Use of ultrarapid acting insulin
|
AR100562A1
(es)
|
2014-05-22 |
2016-10-12 |
Therapeuticsmd Inc |
Composición farmacéutica de estradiol y progesterona para terapia de reemplazo hormonal
|
WO2016018993A1
(en)
|
2014-07-29 |
2016-02-04 |
Therapeuticsmd, Inc. |
Transdermal cream
|
US10561806B2
(en)
|
2014-10-02 |
2020-02-18 |
Mannkind Corporation |
Mouthpiece cover for an inhaler
|
US11510859B2
(en)
*
|
2015-07-16 |
2022-11-29 |
Marinomed Biotech Ag |
Method for improving aqueous solubility of water-insoluble or slightly water-soluble drugs
|
US10328087B2
(en)
|
2015-07-23 |
2019-06-25 |
Therapeuticsmd, Inc. |
Formulations for solubilizing hormones
|
CA2995605C
(en)
*
|
2015-08-17 |
2024-04-02 |
Delivra Inc. |
Transdermal formulations for delivery of berberine compounds, and their use in the treatment of berberine-responsive diseases and conditions
|
KR20180053318A
(ko)
|
2015-09-17 |
2018-05-21 |
제이알엑스 바이오테크놀로지, 인코포레이티드 |
피부 수화 또는 보습을 향상시키기 위한 접근법
|
WO2017096427A1
(en)
|
2015-12-09 |
2017-06-15 |
Phosphagenics Limited |
Pharmaceutical formulation
|
US10688069B2
(en)
|
2016-03-31 |
2020-06-23 |
REV Pharmaceuticals LLC |
Sports health performance composition
|
WO2017173044A1
(en)
|
2016-04-01 |
2017-10-05 |
Therapeuticsmd Inc. |
Steroid hormone compositions in medium chain oils
|
CA3020153A1
(en)
|
2016-04-01 |
2017-10-05 |
Therapeuticsmd, Inc. |
Steroid hormone pharmaceutical composition
|
CN106349206B
(zh)
*
|
2016-08-29 |
2018-09-21 |
珀莱雅化妆品股份有限公司 |
一种从毛喉鞘蕊花中提取福斯高林的制备方法
|
EP3558903A4
(de)
|
2016-12-21 |
2019-11-27 |
Avecho Biotechnology Limited |
Verfahren
|
US10385297B2
(en)
|
2017-03-16 |
2019-08-20 |
The Procter & Gamble Company |
Methods for making encapsulate-containing product compositions
|
US11103465B2
(en)
|
2017-11-22 |
2021-08-31 |
Ted's Brain Science, Inc. |
Trans-resveratrol topical medication for the treatment of pain and method of manufacture thereof
|
US11633405B2
(en)
|
2020-02-07 |
2023-04-25 |
Therapeuticsmd, Inc. |
Steroid hormone pharmaceutical formulations
|
WO2023119230A1
(en)
|
2021-12-22 |
2023-06-29 |
L'oreal |
Coagulation pathway and nicotinamide-adenine dinucleotide pathway modulating compositions and methods of their use
|